NCT06394726

Brief Summary

Dysmenorrhea, derived from ancient Greek, translates to 'difficult monthly flow' and refers to painful cramps during menstruation, a common cause of pelvic pain. The pain, often in the lower abdomen, results from uterine pressure exceeding 60 mmHg. Symptoms include suprapubic pain, radiating discomfort, nausea, diarrhea, and headache, impacting quality of life. Etiology involves factors like age at menarche, heavy flow, lifestyle, and medical conditions. Dysmenorrhea is categorized as primary (without underlying pathology) or secondary (due to conditions like endometriosis). Its prevalence is high in adolescence, affecting daily life, school, and health. Research aims to assess how aerobic and core exercises influence pain and quality of life in adolescent females (14-18 years). Participants are randomly assigned to study and control groups, exploring the potential benefits for health, well-being, and academic performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 1, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

3 months

First QC Date

February 26, 2024

Last Update Submit

July 19, 2024

Conditions

Keywords

Aerobic exerciseCore Stabilization Exercises

Outcome Measures

Primary Outcomes (2)

  • Visual Analog Scale

    VAS is a common tool for assessing subjective experiences like pain or mood intensity. It consists of a 10-centimeter line with clear endpoints representing extreme sensations. Participants mark a point on the line corresponding to their perception, such as "No Pain" to "Worst Pain Imaginable." The distance from "No Pain" provides a quantitative measure. Easy to administer and adaptable, VAS is widely used in clinical and research settings for various subjective states beyond pain, requiring no specialized training. "In this scale, '0' corresponds to the best, and '10' to the worst

    baseline and 12 weeks

  • Functional and Emotional functional and emotional measure of dysmenorrhea (FEMD)

    "FEMD" stands for Functional and Emotional Measure of Dysmenorrhea. Dysmenorrhea refers to painful menstruation, commonly known as menstrual cramps. The FEMD is a tool or scale used to assess both the functional and emotional impacts of dysmenorrhea on individuals. The functional aspect of the FEMD typically evaluates the severity of physical symptoms associated with dysmenorrhea, such as the intensity of pain, its duration, any associated symptoms like nausea or vomiting, and how these symptoms affect daily activities or functioning. The scale consists of 14 items and 2 subscales. Each item is scored on a scale from 1 to 5: (1) Not at all like my condition, (2) Not much like my condition, (3) Somewhat like and somewhat unlike my condition, (4) Much like my condition, (5) Very much like my condition. There are no reverse items. As scores increase on this scale, individuals' levels of functional and emotional impact from dysmenorrhea also increase."

    baseline and 12 weeks

Secondary Outcomes (4)

  • SF-36 Short Form 36 Health Survey

    baseline and 12 weeks

  • A dysmenorrhea monitoring form

    baseline and 12 weeks

  • Dysmenorrhea Impact Scale short form

    baseline and 12 weeks

  • Menstrual Symptom Questionnaire

    baseline and 12 weeks

Study Arms (2)

Aerobic Exercise Group

ACTIVE COMPARATOR

Aerobic Exercise Group For 3 months, participants will engage in a total of 150 minutes of exercise per week, either 30 minutes for 5 days a week or 50 minutes for 3 days a week.

Behavioral: Exercise İntervention

Core Stabilization Exercise Group

ACTIVE COMPARATOR

Core Stabilization Exercise Group for 3 months, 2 sets of exercises, each comprising 10 repetitions per set.

Behavioral: Exercise İntervention

Interventions

Aerobic and Core Stabilization Exercise Intervention

Aerobic Exercise GroupCore Stabilization Exercise Group

Eligibility Criteria

Age14 Years - 18 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Be nulliparous (have not given birth) and be between the ages of 14-18.
  • Volunteer to participate.
  • Have no active sexual life.
  • Have a regular menstrual cycle.
  • Report a pain intensity of 5 or above on the Visual Analog Scale (VAS).
  • Have a Body Mass Index (BMI) between 19 and 24.9.
  • Not have polycystic ovary syndrome or undergone any surgical operation related to female diseases.
  • Not engage in regular exercise.
  • Not have any chronic, systemic, neurological, or endocrinological diseases.

You may not qualify if:

  • Participate in tele-rehabilitation and exercise diary for less than 3 days.
  • Use an intrauterine device.
  • Have taken pharmacological supplements in the last 3 months or during the study tracking period (due to reasons such as flu, COVID, etc.).
  • Have any physical impediment restricting physical activity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Bilgi University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Dysmenorrhea

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Aycan Cakmak Reyhan, PhD

    Istanbul Bilgi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Randomized Controlled Study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 26, 2024

First Posted

May 1, 2024

Study Start

March 1, 2024

Primary Completion

May 30, 2024

Study Completion

June 30, 2024

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations